Yayuan Yu

No ORCID on file · 5 papers in corpus · active 2024-2025

Study types

  • article 2
  • other 2
  • preprint 1

Condition tags

  • adenomyosis 4
  • endometriosis 1
article 2025
Decoding adenomyosis pathogenesis using an assembloid model
Science China. Life sciences ·doi:10.1007/s11427-025-2981-1

Adenomyosis remains a challenging gynecological disorder to investigate due to the absence of in vitro models that accurately replicate endometrial tissue dynamics across the menstrual cycle. To address this gap, we established an endometri…

other 2025
Exosomal miR-92a-3p serves as a promising marker and potential therapeutic target for adenomyosis
Scientific reports ·doi:10.1038/s41598-024-84608-5

This study aimed to elucidate the role of microRNA-92a-3p (miR-92a-3p) in the pathogenesis of adenomyosis. We examined how miR-92a-3p, found in exosomes derived from ectopic lesions, influences the behaviour of endometrial cells, dorsal roo…

other 2024
Comprehensive transcriptional atlas of human adenomyosis deciphered by the integration of single-cell RNA-sequencing and spatial transcriptomics
Protein & cell ·doi:10.1093/procel/pwae012

Adenomyosis is a poorly understood gynecological disorder lacking effective treatments. Controversy persists regarding "invagination" and "metaplasia" theories. The endometrial-myometrial junction (EMJ) connects the endometrium and myometri…

preprint 2024
Exosomal MiR-92a-3p serves as a Promising Diagnostic Marker and Potential Therapeutic Target for Adenomyosis
·doi:10.21203/rs.3.rs-3961335/v1
article 2024
Immunomodulation in Endometriosis: Investigating the interrelationship between VISTA expression and Escherichia.Shigella-Associated metabolites
International immunopharmacology ·doi:10.1016/j.intimp.2024.112366

AIMS: Endometriosis is characterized by an abnormal immune microenvironment. Despite the extensive use of immune therapies, the application of immune checkpoint inhibitors in endometriosis lacks confidence due to the instability of preclini…